OBJECTIVE: To examine the relationship between stated intention to choose electroconvulsive therapy (ECT) as a future treatment option and measures of function and quality of life, mood, and cognition in the month after this therapy. Understanding the factors influencing patient choice of ECT is a source of insight into the interplay between measures of response and perceived value of this treatment to patients, lending perspective to patient-centered quality improvement efforts. METHOD: In a prospective sample of 77 depressed patients given ECT, we surveyed recipients at 1 month about their expressed likelihood of choosing ECT given a future episode and examined predictors of their responses. RESULTS: Thirty-four subjects were classified as "likely" to choose a course of ECT, whereas 33 patients were "unlikely." A model including Hamilton baseline and change scores as well as baseline scores in instrumental activities of daily living significantly predicted likeliness after controlling for age and sex (R = 0.34, P < 0.0001). Other quality-of-life variables and measures of change in cognition were not significant in the model. CONCLUSIONS: In our sample, choosing ECT as a future treatment option was more likely for those who were more depressed before treatment, had more impaired instrumental activities at the outset of treatment, and experienced a more robust improvement in depressive symptoms. This variance was not explained by treatment-associated improvements in quality of life, function, or deficits in cognitive status.
No takes yet. Share an insight, caveat, or question.
Rosenquist et al. (2006) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: